These companies are investing heavily into their pipelines and the payoff for long-term investors can be substantial.

Teva Pharmaceutical Industries Ltd. (TEVA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most ...

Recently, there have been concerns around the surge of fraudulent loans and private credit quality issues in the US.

​This partnership builds on an earlier collaboration, which was launched between the two companies in 2022. As part of this ...

Not just any pharmaceutical stock will do, though. They aren't all created equal. Let's discuss two leaders in the industry ...

CRMD, CELC, RANI, and RAPT are pushing aggressively to the upside on Monday. Here's what is driving these four biotech stocks ...

Over the past decade, pharmaceutical maker Pfizer ( PFE -0.53%) has severely lagged the market. Dividends reinvested aside, ...

Many of the biotech stocks remain outside of Mr. Market's interest zone. Check out five biotech firms that may be of interest ...

Shares of mid-cap oncology specialist Exelixis are worth about $39 each right now. The biotech generates steady revenue and ...

Technical charts show that select pharma stocks are trading with a negative bias and can tumble up to 19% from here. Granules ...

At 24/7 Wall St., we have closely followed dividend-paying stocks for over 15 years. With a growing audience of savvy Baby ...

Christopher Gibson, Chief Executive Officer of Recursion Pharmaceuticals, recently sold a significant chunk of his company's common stock. The CEO of Recursion Pharmaceuticals recently disposed of 120 ...